Archive
Every update, milestone, and publication from Seek Labs.
Seek Labs Announces Returnship Program September 25, 2024 Seek Labs is excited to announce the launch of its Returnship Program in partnership with BioHive. Seek Labs’ Returnship Program aims to support and provide opportunities for individuals who have taken an extended absence from their career. Seek Labs hopes to reduce barriers to employment by actively…
Seek Labs Joins Global African Swine Fever Research Alliance (GARA) September 16, 2024 Seek Labs is excited to announce its participation in the Global African Swine Fever Research Alliance (GARA), a global collaborative effort dedicated to fighting African Swine Fever (ASF). With its innovative CRISPR-based therapeutic technology platform, Seek Labs is set to play a…
Seek Labs at Next Generation Dx Summit in Washington, D.C. August 22, 2024 The 2024 Next Generation Dx Summit, held from August 19-21 in Washington, D.C., was a gathering of forward-thinking minds in point-of-care diagnostic technologies, and Seek Labs was proud to be a key participant and sponsor. Jared Bauer, CEO, delivered a highly anticipated…
Seek Labs to Sponsor and Exhibit at the 2024 Next Generation Dx Summit in Washington, D.C. August 12, 2024 SALT LAKE CITY, UT, August 12, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and a novel CRISPR-based pharmaceutical technology platform, is excited to announce its sponsorship and…
Seek Labs Named Emerging Finalist in Healthcare and Life Sciences Category for 2024 Utah Business Innovation Awards August 8, 2024 Seek Labs is excited to announce its selection as an Emerging finalist in the Healthcare and Life Sciences category for the 2024 Utah Business Innovation Awards. This honor recognizes Seek Labs’ groundbreaking diagnostics innovation, SeekIt™,…
Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop June 12, 2024 Today, Dr. Douglas Gladue, VP of Veterinary Pharmaceutical Development, presented at the PROCINORTE 2024 Priority Animal Diseases Virtual Workshop. Dr. Gladue spoke about Seek Labs’ development of CRISPR-based pharmaceuticals for human and animal diseases. Addressing a virtual assembly…
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development June 3, 2024 SALT LAKE CITY, UTAH, June 3, 2024 (Business Wire)– Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based pharmaceutical technology, is pleased to announce the appointment of Dr.…
Dr. Alison O’Mahony, Vice President of Pharmaceutical Research, Named One of 30 Women to Watch 2024 by Utah Business May 30, 2024 This week, Alison O’Mahony, VP of Pharmaceutical Research, was named one of 30 Women to Watch by Utah Business. Each year, Utah Business honors 30 women throughout the state of Utah who are…
Cindy Dunkle Named a Top 25 Biotech Executive of 2024 by The Healthcare Technology Report May 10, 2024 This week, The Healthcare Technology Report released the honorees for the Top 25 Biotech Executives of 2024. Among the honorees is Cindy Dunkle, one of Seek Labs’ esteemed members of the Board of Directors. As noted by…
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments May 6, 2024 SALT LAKE CITY, UT (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based…
Seek Labs Welcomes Esteemed Diagnostics Industry Innovator and Executive, Dr. Randy Rasmussen, PhD, to Board of Directors March 29, 2024 SALT LAKE CITY, UT, March 29, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, is pleased to announce the appointment of Randy Rasmussen,…
Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors March 19, 2024 SALT LAKE CITY, UT, March 19, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, is pleased to announce the appointment of Michael Paul, PhD to…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.